Trial intelligence / Profile preview

Moxifloxacin vs Amoxicillin + Metronidazole for Generalized Aggressive Periodontitis

NCT02223702Phase 4Completed

Sponsor
Kocaeli University
Start
May 2011
Primary completion
May 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of moxifloxacin in Generalized Aggressive Periodontitis (GAP), sponsored by Kocaeli University. Started May 2011; status: completed.

02

Drugs

moxifloxacin
03

Conditions

Generalized Aggressive Periodontitis (GAP)

Beyond the preview

Go deeper on NCT02223702.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02223702.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call